Peter C. Farrell, PhD, DSc, AM

Type the team member position here…

Peter Farrell is the founder and Chairman of the board of ResMed and has been Chairman and a director since its inception in 1989.  Dr. Farrell served as chief executive officer and/or Executive Chairman from the company’s inception in 1989 until January 2014.  He remains a non-officer employee of ResMed and is still Chairman.

From July 1984 to June 1989 Dr. Farrell served as vice president, research and development at various subsidiaries of Baxter International, Inc. and from August 1985 to June 1989 he also served as managing director of the Baxter Center for Medical Research Pty Ltd, a Baxter subsidiary.  From January 1978 to December 1989 he was foundation director of the Graduate School for Biomedical Engineering at the University of New South Wales where he currently serves as a Visiting Professor and as Chairman of the UNSW Centre for Innovation and Entrepreneurship.  He served on the Visiting Committee of the Harvard/MIT Health Sciences & Technology Program (1998-2018) and currently serves on the MIT Dean of Engineering’s Advisory Council.  In addition, he serves on two faculty advisory boards at the University of California San Diego: the Rady Business School and the Jacobs School of Engineering.  He holds a B.E. in chemical engineering with honors from the University of Sydney, an S.M. in chemical engineering from the Massachusetts Institute of Technology, a Ph.D. in chemical engineering and bioengineering from the University of Washington Seattle and a D.Sc. from the University of New South Wales for research contributions in the field of treatment with the artificial kidney.

From 2005 through May 2018 Dr. Farrell was a director of NuVasive, Inc. a NASDAQ-listed company which develops and markets products for the surgical treatment of spine disorders.  In May 2018, Dr. Farrell was named Chairman of the board of Arcturus Therapeutics Ltd (NASDAQ ARCT), an RNA therapeutics company.  He also chairs Cambridge-based WaveGuide, a company founded on NMR technology developed within Harvard’s School of Physics. 

Dr. Farrell is a fellow or honorary fellow of several professional bodies including being a member of the National Academy of Engineering to which he was elected in 2012.  Dr. Farrell was named 1998 San Diego Entrepreneur of the Year for Health Sciences, Australian Entrepreneur of the Year in 2001 and US National Entrepreneur of the Year for Health Sciences in 2005.  Dr. Farrell joined the Executive Council of the Division of Sleep Medicine at Harvard Medical School in 1998, served as vice chairman from 2000 until 2010 when he became chairman, he served in that capacity until May 2013.  In 2012 he joined the board of trustees of the Scripps Research Institute in La Jolla, CA.